Detalhe da pesquisa
1.
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Br J Haematol
; 204(2): 525-533, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905734
2.
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Br J Haematol
; 200(2): 187-196, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210485
3.
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma.
Br J Haematol
; 193(2): 299-306, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200406
4.
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients.
Eur J Haematol
; 106(3): 428-432, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33247499
5.
Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
Br J Haematol
; 179(5): 849-851, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27605200
6.
Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter's Transformation.
Front Oncol
; 12: 828471, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35174095